Wegener's Granulomatosis (Granulomatosis with Polyangiitis). Difficulties in Diagnosis in the Post-COVID Period
https://doi.org/10.58838/2075-1230-2023-101-6-82-88
Abstract
The article describes a clinical case of Wegener's granulomatosis, which manifested in the post-COVID period in a young man; also it discusses diagnostic difficulties.
About the Authors
B. E. Borodulin
Samara State Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
Boris E. Borodulin, Doctor of Medical Sciences, Professor of Phthisiology and Pulmonology Department
48, Pionerskaya St., Samara, Russia, 443099
E. A. Borodulina
Samara State Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
Elena A. Borodulina, Doctor of Medical Sciences, Head of Phthisiology and Pulmonology Department
48, Pionerskaya St., Samara, Russia, 443099
S. Yu. Pushkin
Samara State Medical University, Russian Ministry of Health; V.D. Seredavin Samara Regional Clinical Hospital
Russian Federation
Russian Federation
Sergey Yu. Pushkin, Doctor of Medical Sciences, Head of Department of Pediatric and Adult Surgical Diseases, Head Physician of V.D. Seredavin Samara Regional Clinical Hospital, Chief Thoracic Surgeon of the Volga Federal District
48, Pionerskaya St., Samara, Russia, 443099
E. S. Vdoushkina
Samara State Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
Elizaveta S. Vdoushkina, Candidate of Medical Sciences, Associate Professor of Phthisiology and Pulmonology Department
48, Pionerskaya St., Samara, Russia, 443099
L. V. Povalyaeva
Samara State Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
Lyudmila V. Povalyaeva, Candidate of Medical Sciences, Associate Professor of Phthisiology and Pulmonology Department
48, Pionerskaya St., Samara, Russia, 443099
References
1. Bagriy A.E., Stupakova K.A., Tkachenko L.I. et al. Vasculitis associated with antibodies to neutrophil cytoplasm (ANCA): state of the problem and clinical and laboratory comparisons. Universitetskaya Klinika, 2020, vol. 37, no. 6, pp. 58-65. (In Russ.) https://doi.org/10.26435/UC.V0I4(37).539
2. Viktorova I.A., Goloshubina V.V., Grishechkina I.A., Bunova S.S. Difficulties and mistakes in the diagnosis of the root causes of fever of unknown genesis (clinical case). Nauchnyye Vedomosti Belgorodskogo State Universiteta, Seriya: Meditsina, Farmatsiya, 2019, vol. 42, no. 3, pp. 273-278. (In Russ.) https://doi.org/10.18413/2075-4728-2019-42-3-273-278.
3. Gurizheva M.V., Nakhusheva A.R., Muskhanov E.A., Kuchmezova F.A., Shabatukova M.Ya., Sarakaeva J.I., Shogenov Kh.K. Rare systemic vasculitis in clinical practice: diagnostic difficulties. Trudny Patsient, 2019, vol. 17, no. 11-12, pp. 36-40. (In Russ.) https://doi.org/10.24411/2074-1995-2019-10085
4. Guseva G.R. A clinical case of an atypical course of systemic vasculitis. Spravochnik Vracha Obshchey Praktiki, 2019, no. 10, pp. 62-73. (In Russ.) https://doi.org/10.33920/med-10-1910-08.
5. Demko I.V., Gordeeva N.V., Mamaeva M.G. et al. Differential diagnostics in the practice of a pulmonologist: granulomatosis with polyangitis. Rossiyskiy Meditsinskiy Journal, 2017, no. 3, pp. 211-213. (In Russ.)
6. Zatoloka P.A., Rodko S.S., Rozhkova A.V. Wegener's granulomatosis in ENT practice. Otorinolaringologiya, Vostochnaya Evropa, 2021, vol. 11, no. 2, pp. 195-204. (In Russ.) https://doi.org/10.34883/PI.2021.11.2.049
7. Levashov I.A., Yarovoy A.A. Idiopathic orbital disease and corticosteroids as first-line treatment: literature review. Lechaschi Vrach, 2020, no. 6, pp. 69-73. (In Russ.) https://doi.org/10.26295/OS.2020.64.89.013.
8. Revta A.M., Korelskiy V.N., Bezhanidze A.M. Damage to the organ of vision in Wegener's disease. Clinical case. Sovremennye Tekhnologii V Oftalmologii, 2022, vol. 46, no. 6, pp. 183-188. (In Russ.) https://doi.org/10.25276/2312-4911-2022-6-183-188.
9. Tinkova V.V., Lekhleyder M.V., Galushko N.A., Lisina O.V., Gelich M.E. Cases of granulomatosis with polyangitis (Wegener's disease) diagnosed in the regional TB dispensary. Tuberculosis and Lung Diseases, 2020, vol. 98, no. 7, pp. 46-53. (In Russ.) https://doi.org/10.21292/2075-1230-2020-98-1- 46-53.
10. Choi H., Park Y.B., Song J., Lee S.W. Unclas-sifiable repeated antineutrophil cytoplasmic antibody (ANCA) positivity in diseases other than ANCA-associated vasculitis // Z Rheumatol – 2021. – Vol.81, №8. – Р.705-711. https://doi.org/10.1007/s00393-021-00998-1
11. Giryes S., Bragazzi N.L., Bridgewood C., De Marco G., McGonagle D. COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells // Semin Immunopathol. – 2022. –Vol.44, №3. – P.375-390. https://doi.org/10.1007/s00281-022-00928-6
12. Huan G., Yang G., Xiao-Yu. Q., et al. Antineutrophil cytoplasmic antibodies in Chinese patients with tuberculosis // Rev Soc Bras Med Trop. – 2018. – Vol.51, №4. – P.475-8. https://doi.org/10.1590/0037-8682-0400-2017
13. Kadkhoda K., Laurita K. Antineutrophil cytoplasmic antibodies and their association with clinical outcomes in hospitalized COVID-19 patients // Cell Death Discovery. – 2021. – Vol. 5, №7(1). – P.277. https://doi.org/10.1038/s41420-021-00671-1.
14. Thai L.H., Charles P., Resche-Rigon M., Desseaux K., Guillevin L. Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? // Autoimmun Rev. – 2014. – Vol.13, №3. – P.313-8. https://doi.org/10.1016/j.autrev.2013.11.003.
15. Theofilis P., Vordoni A., Koukoulaki M., et al. Overview of infections as an etiologic factor and complication in patients with vas-culitides // Rheumatol Int. – 2022. – Vol.42, №5. – P.759-70. https:// doi.org/10.1007/s00296-022-05100-9
16. Van Gool I.C., Kers J., Bakker J.A., et al. Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature // Clin Rheumatol. – 2022. – Vol.41, №10. – P.2949-2960. https://doi.org/10.1007/s10067-022-06240-w.
17. Watts R.A., Mooney J., Skinner J., et al. The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis // Rheumatology. – 2012. –Vol.51, №5. – P. 926-931. https://doi.org/10.1093/rheumatology/ker454
Review
For citations:
Borodulin B.E., Borodulina E.A., Pushkin S.Yu., Vdoushkina E.S., Povalyaeva L.V. Wegener's Granulomatosis (Granulomatosis with Polyangiitis). Difficulties in Diagnosis in the Post-COVID Period. Tuberculosis and Lung Diseases. 2023;101(6):82-88. (In Russ.) https://doi.org/10.58838/2075-1230-2023-101-6-82-88
Views:
339
Email this article 